Literature DB >> 15967067

Basophils and mast cells in chronic idiopathic urticaria.

Becky M Vonakis1, Sarbjit S Saini.   

Abstract

Chronic idiopathic urticaria (CIU) is diagnosed in patients when urticarial eruptions recur for more than 6 weeks, and no specific cause is determined. Given that urticaria resembles the lesions induced by injection of histamine or allergen into the skin, a role for mast cells or basophils has been proposed in the generation of localized urticarial lesions. However, currently, the exact mechanisms governing regional mast cell or basophil activation are unknown. In the past decade, there has been mounting interest in viewing CIU as an autoimmune disease, given the presence of circulating autoantibodies to IgE or the alpha subunit of the high-affinity IgE receptor (FceRI) in a subset of patients. In this review, we propose that in addition to autoantibodies, specific differences in the expression of FceRI-signaling molecules in the basophils or mast cells of CIU patients may contribute to the generation of urticarial eruptions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967067     DOI: 10.1007/s11882-005-0066-0

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  55 in total

1.  The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation.

Authors:  M Huber; C D Helgason; J E Damen; L Liu; R K Humphries; G Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

2.  Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals.

Authors:  Marzia Caproni; Barbara Giomi; Walter Volpi; Lucilla Melani; Emiliano Schincaglia; Donatella Macchia; Mariangela Manfredi; Alberino D'Agata; Paolo Fabbri
Journal:  Clin Immunol       Date:  2005-03       Impact factor: 3.969

3.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Authors:  Sonia Varadaradjalou; Frédéric Féger; Nathalie Thieblemont; Nadine Ben Hamouda; Jean-Marie Pleau; Michel Dy; Michel Arock
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

4.  Mechanisms of autoimmune activation of basophils in chronic urticaria.

Authors:  Y Kikuchi; A P Kaplan
Journal:  J Allergy Clin Immunol       Date:  2001-06       Impact factor: 10.793

5.  Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.

Authors:  R A Sabroe; P T Seed; D M Francis; R M Barr; A K Black; M W Greaves
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

6.  Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship.

Authors:  E Fiebiger; F Hammerschmid; G Stingl; D Maurer
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

7.  Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.

Authors:  R A Sabroe; E Poon; G E Orchard; D Lane; D M Francis; R M Barr; M M Black; A K Black; M W Greaves
Journal:  J Allergy Clin Immunol       Date:  1999-03       Impact factor: 10.793

8.  Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity.

Authors:  Ruth A Sabroe; Edda Fiebiger; David M Francis; Dieter Maurer; Paul T Seed; Clive E h Grattan; Anne Kobza Black; Georg Stingl; Malcolm W Greaves; Robert M Barr
Journal:  J Allergy Clin Immunol       Date:  2002-09       Impact factor: 10.793

9.  Defective histamine release in chronic urticaria.

Authors:  F Kern; L M Lichtenstein
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

10.  Mast cell number and phenotype in chronic idiopathic urticaria.

Authors:  C H Smith; C Kepley; L B Schwartz; T H Lee
Journal:  J Allergy Clin Immunol       Date:  1995-09       Impact factor: 10.793

View more
  4 in total

Review 1.  Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease.

Authors:  Clifton O Bingham
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

2.  Development of a microarray-based method to detect exposure of human basophils to IL-3.

Authors:  Donald MacGlashan
Journal:  J Immunol Methods       Date:  2012-08-14       Impact factor: 2.303

3.  Expression profiling of human basophils: modulation by cytokines and secretagogues.

Authors:  Donald MacGlashan
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

4.  Investigating the association of atopy and aeroallergen sensitization and chronic spontaneous urticaria.

Authors:  Hossein Esmaeilzadeh; Mehrdad Eskandarisani; Hesamedin Nabavizadeh; Soheila Alyasin; Mouhebat Vali; Negar Mortazavi
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.